Effects of different doses of levosimendan combined with Shenmai injection on immune function and galectin-3 and HSP70 levels in rats with acute heart failure

References

• Baggen VJM, van den Bosch AE, Eindhoven JA, Menting ME, Witsenburg M, Cuypers J, Boersma E, Roos-Hesselink JW. 2018. Prognostic value of galectin-3 in adults with congenital heart disease. Heart. 104(5):394–400.
   PubMed Web of Science ®Google Scholar
• Cabiati M, Botta L, Caselli C, Del Ry S. 2020. Transcriptional evaluation of relaxin and endothelin-1 axis in heart failure patients: first evidence of its involvement during left ventricular assist device support. Int J Cardiol. 306:109–115.
   Web of Science ®Google Scholar
• Chen LJ, Zhang RG, Yu DD, Wu G, Dong XR. 2019. Shenqi Fuzheng injection ameliorates radiation-induced brain injury. Curr Med Sci. 39(6):965–971.
   Web of Science ®Google Scholar
• Chen Q, Huang M, Wu J, Jiang Q, Zheng X. 2020a. Exosomes isolated from the plasma of remote ischemic conditioning rats improved cardiac function and angiogenesis after myocardial infarction through targeting Hsp70. Aging. 12(4):3682–3693.
   Google Scholar
• Chen RJ, Rui QL, Wang Q, Tian F, Wu J, Kong XQ. 2020b. Shenfu injection attenuates lipopolysaccharide-induced myocardial inflammation and apoptosis in rats. Chin J Nat Med. 18(3):226–233.
   Web of Science ®Google Scholar
• Cheng Y, Rong J. 2019. Pro-resolving lipid mediators as therapeutic leads for cardiovascular diseases. Expert Opin Ther Targets. 23(5):423–436.
   PubMed Web of Science ®Google Scholar
• Comín-Colet J, Manito N, Segovia-Cubero J, Delgado J, García Pinilla JM, Almenar L, Crespo-Leiro MG, Sionis A, Blasco T, Pascual-Figal D, et al. 2018. Efficacy and safety of intermittent intravenous outpatient administration of levosimendan in patients with advanced heart failure: the LION-HEART multicentre randomised trial. Eur J Heart Fail. 20(7):1128–1136.
   PubMed Web of Science ®Google Scholar
• Eskandari V, Amirzargar AA, Mahmoudi MJ, Rahnemoon Z, Rahmani F, Sadati S, Rahmati Z, Gorzin F, Hedayat M, Rezaei N. 2018. Gene expression and levels of IL-6 and TNFα in PBMCs correlate with severity and functional class in patients with chronic heart failure. Ir J Med Sci. 187(2):359–368.
   PubMed Web of Science ®Google Scholar
• Fu R, Noguchi H, Kaneko S, Kawamura A, Kang C, Takahashi H, Tamiya N. 2019. How do cardiovascular diseases harm labor force participation? Evidence of nationally representative survey data from Japan, a super-aged society. PLoS One. 14(7):e0219149.
   Web of Science ®Google Scholar
• Gu T, Wang RH, Wu T, Ke ZH, Yang H, Wang D. 2020. [Therapeutic effect on mild perimenopausal depression treated with acupuncture at the “thirteen ghost points” and kaixin powder]. Zhongguo Zhen Jiu. 40(3):267–271.
   Google Scholar
• Gulyaev NI, Akhmetshin IM, Gordienco AV, Yakovlev VV. 2020. Sarcopenia as the reason of hypodiagnostics of chronic kidney disease in patients with chronic heart failure. Adv Gerontol. 33(1):121–126.
   Google Scholar
• Hansen MS, Andersen A, Nielsen-Kudsk JE. 2018. Levosimendan in pulmonary hypertension and right heart failure. Pulm Circ. 8(3):2045894018790905.
   Web of Science ®Google Scholar
• Hong T, Li LX, Han XP, Shi JL, Dan CY, Liu ZY, Wu XB. 2020. Effect of Astragalus membranaceus oral solution on lifespan and learning and memory ability of honey bees. Biomed Res Int. 2020:5745048.
   Web of Science ®Google Scholar
• Jiang YR, Du JY, Wang DD, Yang X. 2018. miRNA-130a improves cardiac function by down-regulating TNF-α expression in a rat model of heart failure. Eur Rev Med Pharmacol Sci. 22(23):8454–8461.
   PubMed Web of Science ®Google Scholar
• Johnson JL. 2019. Elucidating the contributory role of microRNA to cardiovascular diseases (a review). Vascul Pharmacol. 114:31–48.
   Web of Science ®Google Scholar
• Levijoki J, Pollesello P, Kaheinen P, Haikala H. 2001. Improved survival with levosimendan after experimental myocardial infarction in rats. Eur J Pharmacol. 419(2–3):243–248.
   Web of Science ®Google Scholar
• Li F, Zhang D, Lu X, Wang Y, Xiong Z. 2004. Enatiomeric analysis of levosimendan by CE with beta-CD as chiral selector compared with CMPA-HPLC. Biomed Chromatogr. 18(10):866–871.
   Web of Science ®Google Scholar
• Li L, Yang D, Li J, Niu L, Chen Y, Zhao X, Oduro PK, Wei C, Xu Z, Wang Q, et al. 2020. Investigation of cardiovascular protective effect of Shenmai injection by network pharmacology and pharmacological evaluation. BMC Complement Med Ther. 20(1):112.
   Google Scholar
• Lino DOC, Freitas IA, Meneses GC, Martins AMC, Daher EF, Rocha JHC, Silva Junior GB. 2019. Interleukin-6 and adhesion molecules VCAM-1 and ICAM-1 as biomarkers of post-acute myocardial infarction heart failure. Braz J Med Biol Res. 52(12):e8658.
   Web of Science ®Google Scholar
• Mazloumi E, Poorolajal J, Sarrafzadegan N, Roohafza HR, Faradmal J, Karami M. 2019. Avoidable burden of cardiovascular diseases in the eastern Mediterranean region: contribution of selected risk factors for cardiovascular-related deaths. High Blood Press Cardiovasc Prev. 26(3):227–237.
   Web of Science ®Google Scholar
• Mohamed AS, Hosney M, Bassiony H, Hassanein SS, Soliman AM, Fahmy SR, Gaafar K. 2020. Sodium pentobarbital dosages for exsanguination affect biochemical, molecular and histological measurements in rats. Sci Rep. 10(1):378.
   Web of Science ®Google Scholar
• Noale M, Limongi F, Maggi S. 2020. Epidemiology of cardiovascular diseases in the elderly. Adv Exp Med Biol. 1216:29–38.
   PubMed Web of Science ®Google Scholar
• Papp Z, Agostoni P, Alvarez J, Bettex D, Bouchez S, Brito D, Černý V, Comin-Colet J, Crespo-Leiro MG, Delgado JF. 2020. Levosimendan efficacy and safety: 20 years of SIMDAX in clinical use. Card Fail Rev. 6:e19.
   PubMedGoogle Scholar
• Pu X, Chai Y, Guan L, Li W, Gao J, Jiang Z, Li Q, Wu Y, Chen Y. 2020. Astragalus improve aging bone marrow mesenchymal stem cells (BMSCs) vitality and osteogenesis through VD-FGF23-Klotho axis. Int J Clin Exp Pathol. 13(4):721–729.
   PubMed Web of Science ®Google Scholar
• Raczkiewicz D, Bojar I, Wdowiak A, Rzeźnicki A, Krakowiak J. 2019. Stress at intellectual work and cardiovascular diseases in women at non-mobility working age. Ann Agric Environ Med. 26(3):456–461.
   Web of Science ®Google Scholar
• Segiet OA, Piecuch A, Mielanczyk L, Michalski M, Nowalany-Kozielska E. 2019. Role of interleukins in heart failure with reduced ejection fraction. Anatol J Cardiol. 22(6):287–299.
   PubMed Web of Science ®Google Scholar
• Shen Q, Chen W, Liu J, Liang Q. 2019. Galectin-3 aggravates pulmonary arterial hypertension via immunomodulation in congenital heart disease. Life Sci. 232:116546.
   PubMed Web of Science ®Google Scholar
• Shi H, Wang L, Fang ZH, Ni YQ, Shen AL, Liu PP, Wang X, Huang JL. 2019. [Experimental study on effect and mechanism of Danzhi Jiangtang Capsules on diabetic myocardial injury]. Zhongguo Zhong Yao Za Zhi. 44(23):5159–5165.
   Google Scholar
• Song N, Ma J, Meng XW, Liu H, Wang H, Song SY, Chen QC, Liu HY, Zhang J, Peng K. 2020. Heat shock protein 70 protects the heart from ischemia/reperfusion injury through inhibition of p38 MAPK signaling. Oxid Med Cell Longev. 2020:3908641.
   Web of Science ®Google Scholar
• Tulay P, Temel SG, Ergoren MC. 2019. Investigation of KCNQ1 polymorphisms as biomarkers for cardiovascular diseases in the Turkish Cypriots for establishing preventative medical measures. Int J Biol Macromol. 124:537–540.
   Web of Science ®Google Scholar
• Wang A, Cui C, Fan Y, Zi J, Zhang J, Wang G, Wang F, Wang J, Tan Q. 2019a. Prophylactic use of levosimendan in pediatric patients undergoing cardiac surgery: a prospective randomized controlled trial. Crit Care. 23(1):428.
   PubMed Web of Science ®Google Scholar
• Wang C, Yao D, Zhang P, Xie X, Wang B, Liu J, Zhang Z. 2019b. Clinical efficacy and safety of Shenqi Fuzheng injection for the treatment of chronic heart failure: protocol for a meta-analysis and systematic review. Medicine (Baltimore). 98(52):e18556.
   Web of Science ®Google Scholar
• Xu T, Ding W, Ji X, Ao X, Liu Y, Yu W, Wang J. 2019. Oxidative stress in cell death and cardiovascular diseases. Oxid Med Cell Longev. 2019:9030563.
   PubMed Web of Science ®Google Scholar
• Yang F, Zhao LN, Sun Y, Chen Z. 2019. Levosimendan as a new force in the treatment of sepsis-induced cardiomyopathy: mechanism and clinical application. J Int Med Res. 47(5):1817–1828.
   PubMed Web of Science ®Google Scholar
• Yang L, Zhang C, Chen J, Zhang S, Pan G, Xin Y, Lin L, You Z. 2020. Shenmai injection suppresses multidrug resistance in MCF-7/ADR cells through the MAPK/NF-κB signalling pathway. Pharm Biol. 58(1):276–285.
   PubMed Web of Science ®Google Scholar
• You JS, Huang HF, Chang YL, Lee YS. 2006. Sheng-mai-san reduces adriamycin-induced cardiomyopathy in rats. Am J Chin Med. 34(2):295–305.
   Web of Science ®Google Scholar
• Zhang MJ, Gu Y, Wang H, Zhu PF, Liu XY, Wu J. 2016. Valsartan attenuates cardiac and renal hypertrophy in rats with experimental cardiorenal syndrome possibly through down-regulating galectin-3 signaling. Eur Rev Med Pharmacol Sci. 20(2):345–354.
   Web of Science ®Google Scholar